232 related articles for article (PubMed ID: 19067573)
1. Affinity classification of kinase inhibitors by mass spectrometric methods and validation using standard IC(50) measurements.
Jecklin MC; Touboul D; Jain R; Toole EN; Tallarico J; Drueckes P; Ramage P; Zenobi R
Anal Chem; 2009 Jan; 81(1):408-19. PubMed ID: 19067573
[TBL] [Abstract][Full Text] [Related]
2. Structural basis of Src tyrosine kinase inhibition with a new class of potent and selective trisubstituted purine-based compounds.
Dalgarno D; Stehle T; Narula S; Schelling P; van Schravendijk MR; Adams S; Andrade L; Keats J; Ram M; Jin L; Grossman T; MacNeil I; Metcalf C; Shakespeare W; Wang Y; Keenan T; Sundaramoorthi R; Bohacek R; Weigele M; Sawyer T
Chem Biol Drug Des; 2006 Jan; 67(1):46-57. PubMed ID: 16492148
[TBL] [Abstract][Full Text] [Related]
3. 3,4-Diaryl-isoxazoles and -imidazoles as potent dual inhibitors of p38alpha mitogen activated protein kinase and casein kinase 1delta.
Peifer C; Abadleh M; Bischof J; Hauser D; Schattel V; Hirner H; Knippschild U; Laufer S
J Med Chem; 2009 Dec; 52(23):7618-30. PubMed ID: 19591487
[TBL] [Abstract][Full Text] [Related]
4. Development of a fluorescent-tagged kinase assay system for the detection and characterization of allosteric kinase inhibitors.
Simard JR; Getlik M; Grütter C; Pawar V; Wulfert S; Rabiller M; Rauh D
J Am Chem Soc; 2009 Sep; 131(37):13286-96. PubMed ID: 19572644
[TBL] [Abstract][Full Text] [Related]
5. A general technique to rank protein-ligand binding affinities and determine allosteric versus direct binding site competition in compound mixtures.
Annis DA; Nazef N; Chuang CC; Scott MP; Nash HM
J Am Chem Soc; 2004 Dec; 126(47):15495-503. PubMed ID: 15563178
[TBL] [Abstract][Full Text] [Related]
6. Implications for selectivity of 3,4-diarylquinolinones as p38alphaMAP kinase inhibitors.
Peifer C; Urich R; Schattel V; Abadleh M; Röttig M; Kohlbacher O; Laufer S
Bioorg Med Chem Lett; 2008 Feb; 18(4):1431-5. PubMed ID: 18207396
[TBL] [Abstract][Full Text] [Related]
7. p38alpha mitogen-activated protein kinase inhibitors: optimization of a series of biphenylamides to give a molecule suitable for clinical progression.
Aston NM; Bamborough P; Buckton JB; Edwards CD; Holmes DS; Jones KL; Patel VK; Smee PA; Somers DO; Vitulli G; Walker AL
J Med Chem; 2009 Oct; 52(20):6257-69. PubMed ID: 19772287
[TBL] [Abstract][Full Text] [Related]
8. A fragment-based approach for the discovery of isoform-specific p38alpha inhibitors.
Chen J; Zhang Z; Stebbins JL; Zhang X; Hoffman R; Moore A; Pellecchia M
ACS Chem Biol; 2007 May; 2(5):329-36. PubMed ID: 17465519
[TBL] [Abstract][Full Text] [Related]
9. Thermal denaturation: a method to rank slow binding, high-affinity P38alpha MAP kinase inhibitors.
Kroe RR; Regan J; Proto A; Peet GW; Roy T; Landro LD; Fuschetto NG; Pargellis CA; Ingraham RH
J Med Chem; 2003 Oct; 46(22):4669-75. PubMed ID: 14561086
[TBL] [Abstract][Full Text] [Related]
10. High-throughput screening to identify inhibitors which stabilize inactive kinase conformations in p38alpha.
Simard JR; Grütter C; Pawar V; Aust B; Wolf A; Rabiller M; Wulfert S; Robubi A; Klüter S; Ottmann C; Rauh D
J Am Chem Soc; 2009 Dec; 131(51):18478-88. PubMed ID: 19950957
[TBL] [Abstract][Full Text] [Related]
11. Pyrrole derivatives as potent inhibitors of lymphocyte-specific kinase: Structure, synthesis, and SAR.
Takayama T; Umemiya H; Amada H; Yabuuchi T; Shiozawa F; Katakai H; Takaoka A; Yamaguchi A; Endo M; Sato M
Bioorg Med Chem Lett; 2010 Jan; 20(1):108-11. PubMed ID: 19945869
[TBL] [Abstract][Full Text] [Related]
12. Biological evaluation and structural determinants of p38α mitogen-activated-protein kinase and c-Jun-N-terminal kinase 3 inhibition by flavonoids.
Goettert M; Schattel V; Koch P; Merfort I; Laufer S
Chembiochem; 2010 Dec; 11(18):2579-88. PubMed ID: 21108268
[TBL] [Abstract][Full Text] [Related]
13. The development of 2-benzimidazole substituted pyrimidine based inhibitors of lymphocyte specific kinase (Lck).
Sabat M; VanRens JC; Laufersweiler MJ; Brugel TA; Maier J; Golebiowski A; De B; Easwaran V; Hsieh LC; Walter RL; Mekel MJ; Evdokimov A; Janusz MJ
Bioorg Med Chem Lett; 2006 Dec; 16(23):5973-7. PubMed ID: 16997556
[TBL] [Abstract][Full Text] [Related]
14. Ring-fused pyrazole derivatives as potent inhibitors of lymphocyte-specific kinase (Lck): Structure, synthesis, and SAR.
Takayama T; Umemiya H; Amada H; Yabuuchi T; Koami T; Shiozawa F; Oka Y; Takaoka A; Yamaguchi A; Endo M; Sato M
Bioorg Med Chem Lett; 2010 Jan; 20(1):112-6. PubMed ID: 19945867
[TBL] [Abstract][Full Text] [Related]
15. Relative contributions of desolvation, inter- and intramolecular interactions to binding affinity in protein kinase systems.
Sims PA; Wong CF; Vuga D; McCammon JA; Sefton BM
J Comput Chem; 2005 May; 26(7):668-81. PubMed ID: 15754303
[TBL] [Abstract][Full Text] [Related]
16. Disubstituted pyrimidines as Lck inhibitors.
Hunt JA; Beresis RT; Goulet JL; Holmes MA; Hong XJ; Kovacs E; Mills SG; Ruzek RD; Wong F; Hermes JD; Park YW; Salowe SP; Sonatore LM; Wu L; Woods A; Zaller DM; Sinclair PJ
Bioorg Med Chem Lett; 2009 Sep; 19(18):5440-3. PubMed ID: 19674899
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for the high-affinity binding of pyrrolotriazine inhibitors of p38 MAP kinase.
Sack JS; Kish KF; Pokross M; Xie D; Duke GJ; Tredup JA; Kiefer SE; Newitt JA
Acta Crystallogr D Biol Crystallogr; 2008 Jul; D64(Pt 7):705-10. PubMed ID: 18566506
[TBL] [Abstract][Full Text] [Related]
18. MALDI-TOF mass-spectrometry-based versatile method for the characterization of protein kinases.
Kondo N; Nishimura S
Chemistry; 2009; 15(6):1413-21. PubMed ID: 19115309
[TBL] [Abstract][Full Text] [Related]
19. The discovery of novel protein kinase inhibitors by using fragment-based high-throughput x-ray crystallography.
Gill A; Cleasby A; Jhoti H
Chembiochem; 2005 Mar; 6(3):506-12. PubMed ID: 15696598
[TBL] [Abstract][Full Text] [Related]
20. Modeling the binding affinity of p38α MAP kinase inhibitors by partial least squares regression.
Basant N; Durante C; Cocchi M; Menziani MC
Chem Biol Drug Des; 2012 Sep; 80(3):455-70. PubMed ID: 22642504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
